Literature DB >> 17382516

To smell autoimmunity: anti-P-ribosomal autoantibodies, depression, and the olfactory system.

Yehuda Shoenfeld1.   

Abstract

Central Nervous System involvement in Systemic Lupus Erythematosus (CNS-SLE) is very common and ranges between 25%-70% of the patients. The CNS involvement is listed in the ARA criteria for SLE diagnosis. CNS-SLE is associated with more than 20 different autoantibodies. Yet, remarkable among them are the anti-P-ribosomal antibodies (anti-PR). These autoantibodies directed mainly against the carboxy 22 amino acids of the PO, P1 P2 ribosomal phosphoproteins. They are capable of penetrating lived cells and inducing apoptotic changes as well as leading to inhibition of specific cytokine secretion. The titer of the autoantibodies correlate with disease activity, kidney involvement and hepatitis. In this review, the mechanisms involved in CNS involvement and its relationship with anti-P ribosomal antibodies will be described.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17382516     DOI: 10.1016/j.jaut.2007.02.012

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  17 in total

1.  The olfactory function is impaired in patients with idiopathic inflammatory myopathies.

Authors:  L Iaccarino; N Shoenfeld; M Rampudda; M Zen; M Gatto; A Ghirardello; N Bassi; L Punzi; Y Shoenfeld; A Doria
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  The catastrophic antiphospholipid syndrome in Serbia: diagnostic and management problems.

Authors:  Ljudmila Stojanovich
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

3.  Decreased olfactory bulb volumes in patients with fibromyalgia syndrome.

Authors:  Selçuk Sayılır; Neşat Çullu
Journal:  Clin Rheumatol       Date:  2017-07-26       Impact factor: 2.980

4.  Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case-control study from a single center.

Authors:  Melissa Padovan; Gabriella Castellino; Alessandra Bortoluzzi; Luisa Caniatti; Francesco Trotta; Marcello Govoni
Journal:  Rheumatol Int       Date:  2010-07-31       Impact factor: 2.631

Review 5.  Smell and autoimmunity: a comprehensive review.

Authors:  Carlo Perricone; Netta Shoenfeld; Nancy Agmon-Levin; Caterina de Carolis; Roberto Perricone; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

6.  The future of autoimmunity.

Authors:  Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

7.  Immunology, autoimmunity, and autoantibodies in Parkinson's disease.

Authors:  Michal Benkler; Nancy Agmon-Levin; Sharon Hassin-Baer; Oren S Cohen; Oscar-Danilo Ortega-Hernandez; Amalia Levy; Samuel-Datum Moscavitch; Martine Szyper-Kravitz; Maya Damianovich; Miri Blank; Joab Chapman; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

8.  Olfactory impairment in patients with the fibromyalgia syndrome and systemic sclerosis.

Authors:  Howard Amital; Nancy Agmon-Levin; Netta Shoenfeld; Yoav Arnson; Daniela Amital; Pnina Langevitz; Alexandra Balbir Gurman; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

9.  Neuropsychiatric lupus and association with cerebrospinal fluid immunoglobulins: a pilot study.

Authors:  Ljudmila Stojanovich; Dusica Smiljanich-Miljkovich; Roald Omdal; Boris Sakic
Journal:  Isr Med Assoc J       Date:  2009-06       Impact factor: 0.892

10.  Comparison of three anti-CCP antibody tests and rheumatoid factor in RA and control patients.

Authors:  Ma Lurdes Correia; Saudade Carvalho; Jorge Fortuna; Ma Henriqueta Pereira
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.